D422-2720 Screening compound: 3-[3-(6-methyl-2-oxo-1-propyl-1,2-dihydropyridin-3-yl)-1,2,4-oxadiazol-5-yl]-N-(3-methylpyridin-2-yl)propanamide

D422-2720 Screening compound: 3-[3-(6-methyl-2-oxo-1-propyl-1,2-dihydropyridin-3-yl)-1,2,4-oxadiazol-5-yl]-N-(3-methylpyridin-2-yl)propanamide
D422-2720 Screening compound: 3-[3-(6-methyl-2-oxo-1-propyl-1,2-dihydropyridin-3-yl)-1,2,4-oxadiazol-5-yl]-N-(3-methylpyridin-2-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D422-2720
3-[3-(6-methyl-2-oxo-1-propyl-1,2-dihydropyridin-3-yl)-1,2,4-oxadiazol-5-yl]-N-(3-methylpyridin-2-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D422-2720

Molecular Formula

C20H23N5O3 (C20 H23 N5 O3)

Compound Name

3-[3-(6-methyl-2-oxo-1-propyl-1,2-dihydropyridin-3-yl)-1,2,4-oxadiazol-5-yl]-N-(3-methylpyridin-2-yl)propanamide

IUPAC name

3-[3-(6-methyl-2-oxo-1-propyl-12-dihydropyridin-3-yl)-124-oxadiazol-5-yl]-N-(3-methylpyridin-2-yl)propanamide

SMILES

CCCN(C(C)=CC=C1c2noc(CCC(Nc3ncccc3C)=O)n2)C1=O

InChI

InChI=1S/C20H23N5O3/c1-4-12-25-14(3)7-8-15(20(25)27)19-23-17(28-24-19)10-9-16(26)22-18-13(2)6-5-11-21-18/h5-8,11H,4,9-10,12H2,1-3H3,(H,21,22,26)

InChI Key

IKUKVQAGVFYJFQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27585207

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

381.43

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.602

Distribution Coefficient, logD

2.601

Water Solubility, LogSw

-2.67

Polar Surface Area

79.585

Acid Dissociation Constant (pKa)

10.37

Base Dissociation Constant (pKb)

3.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

D422-2720 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D422-2720 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D422-2720?
Check Price and Availability of D422-2720, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D422-2720 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D422-2720
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D422-2720
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D422-2720 available by request